Lineus Medical

Provides the Opportunity to Sell SafeBreak® Vascular in International Markets

Lineus Medical announces publication of the randomized controlled trial performed at Colorado State University Veterinary Teaching Hospital in the Journal of the American Veterinary Medical Association.

Lineus Medical continues to expand its patent portfolio with the issuance of two new patents. The first issued patent was a Japanese Utility Patent (JP7095097) for SafeBreak® Vascular, a break-away medical device that helps protect peripheral IV lines.

Contract awarded for products that bring improvement to health care industry

Lineus Medical announces the publication of a pivotal clinical study performed at Hartford Hospital, part of Hartford HealthCare in Hartford, Connecticut, in the March edition of The Journal of Infusion Nursing.

Lineus Medical signed on its fifth distributor in as many months as it continues to expand its distribution network with the addition of Clinical Technology, a specialty distributor of medical products based out of Brecksville, OH.

Lineus Medical has signed its first international distributor, ONEY of Seoul, South Korea.

Lineus Medical continues to expand its distribution network with the addition of The Bimeco Group, a specialty sales and distribution organization based out of Peachtree City, GA.

After securing two new distribution partnerships in the final months of 2021, Lineus Medical continues to expand its distribution network with the addition of Capitol Medical, a specialty medical distributor based out of Harrisburg, PA.

Lineus Medical, after receiving FDA clearance in May 2021 for its flagship product – SafeBreak Vascular, continues to expand its distribution network into the Northeast with the signing of New England Medical Specialties.